Center for Scientific Review Notice of Closed Meeting, 458 [2019-00203]
Download as PDF
458
Federal Register / Vol. 84, No. 19 / Tuesday, January 29, 2019 / Notices
public education. Authorizing
Legislation comes from Section 301 of
the Public Health Service Act (42 U.S.C.
241). Successful execution of BSPB’s
public health mission requires data
collection activities in collaboration
with the state health department in
Puerto Rico and with local veterinary
clinics and animal shelters participating
in the study.
These activities include collecting
information about dogs that meet the
study case definition for a suspect case
of leptospirosis seen at participating
veterinary clinics and shelters.
Participating veterinarians and their
veterinary staff collect information by
interviewing the dog owner (shelters are
an exception as dog will not have an
history, clinical signs and symptoms,
laboratory results, and clinical outcome.
Approval of this revision ICR will allow
BSPB to continue to collect information
which can help inform animal public
health and will help contribute to a One
Health understanding of leptospirosis in
Puerto Rico.
BSPB estimates involvement of at
least 411 respondents (a minimum 385
from the general public and 26
veterinarians and their veterinary staff)
and estimates a total of 168 hours of
burden for research activities each year.
The collected information will not
impose a cost burden on the
respondents beyond that associated
with their time to provide the required
data.
owner) and reviewing medical and
administrative records, as necessary.
Basic information about the
participating sites will also be collected
for study management and to enhance
data analysis.
Information will be collected using
paper forms and provided in Spanish.
Staff at participating sites find it easier
to complete a paper copy when
abstracting medical record information
and interviewing owners for
information about their dog’s risk
factors and symptoms. Study
coordinators will enter collected data
into an electronic database.
The types of information collected
include information about the dog’s
signalment, location of residence,
environmental risk factors, vaccination
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
(in hours)
Type of respondents
Form name
Veterinarians or veterinary staff ........
26
1
5/60
2
Veterinarians or veterinary staff ........
Veterinarians or veterinary staff ........
Dog owners (general public) .............
Enrollment Questionnaire (Attachment C).
Log Sheet (Attachment D) ...............
Case Questionnaire (Attachment E)
Case Questionnaire (Attachment E)
26
26
624
24
24
1
1/60
10/60
5/60
10
104
52
Total ...........................................
...........................................................
........................
........................
........................
168
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019–00276 Filed 1–28–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
16:14 Jan 28, 2019
Jkt 247001
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Cellular and Molecular
Biology of Neurodegeneration Study Section.
Date: January 31–February 1, 2019.
Time: 8:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Catamaran Hotel, 3999 Mission
Boulevard, San Diego, CA 92109.
Contact Person: Laurent Taupenot, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, taupenol@csr.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 18, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00203 Filed 1–28–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00008
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer
Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\29JAN1.SGM
29JAN1
Agencies
[Federal Register Volume 84, Number 19 (Tuesday, January 29, 2019)]
[Notices]
[Page 458]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00203]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Cellular and Molecular Biology
of Neurodegeneration Study Section.
Date: January 31-February 1, 2019.
Time: 8:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Catamaran Hotel, 3999 Mission Boulevard, San Diego, CA
92109.
Contact Person: Laurent Taupenot, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD
20892, 301-435-1203, taupenol@csr.nih.gov.
This meeting notice is being published less than 15 days in
advance of the meeting due to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 18, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00203 Filed 1-28-19; 8:45 am]
BILLING CODE 4140-01-P